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MelanomaCell proliferation is crucial to tissue growth and form during embryogenesis, yet dynamic tracking of cell
cycle progression and cell position presents a challenging roadblock. We have developed a ﬂuorescent cell
cycle indicator and single cell analysis method, called CycleTrak, which allows for better spatiotemporal res-
olution and quantiﬁcation of cell cycle phase and cell position than current methods. Our method was devel-
oped on the basis of the existing Fucci method. CycleTrak uses a single lentiviral vector that integrates mKO2-
hCdt1 (30/120), and a nuclear-localized eGFP reporter. The single vector and nuclear localized ﬂuorescence
signals simplify delivery into cells and allow for rapid, automated cell tracking and cell cycle phase readout
in single and subpopulations of cells. We validated CycleTrak performance in metastatic melanoma cells
and identiﬁed novel cell cycle dynamics in vitro and in vivo after transplantation and 3D confocal time-
lapse imaging in a living chick embryo.
© 2012 Elsevier Inc. All rights reserved.Introduction
The cell cycle consists of 4 phases (G1, S, G2, M) during which a
cell goes through periods of growth, chromosome replication and mi-
tosis. Intrinsic properties of the cell and signals from the local micro-
environment are thought to inﬂuence when the cell enters each
phase of the cycle (Ho and Dowdy, 2002). The inability of a cell to cor-
rectly regulate its entry into different phases of the cell cycle in-
creases genomic instability and may lead to programmed cell death
or cancer (Nurse, 2000). Dynamic tracking of cell cycle progression
and cell position presents a challenging roadblock. The ﬁrst step in
determining the cell cycle proﬁle of a cell is the accurate classiﬁcation
of each of its phases. Second, measuring the dynamics of cell cycle
proﬁle and linking this to cell position requires the spatiotemporal
readout of cell cycle events. Thus, the development of tools to accu-
rately determine cell cycle phase and cell position would offer a pow-
erful approach and may signiﬁcantly impact studies of cell cycle
regulation during events in embryo and adult morphogenesis, tissue
regeneration, and cancer.
Cell cycle phase analysis is typically limited to static, ﬁxed-tissue
methods such as 5-bromo-2′-deoxyuridine (BrdU) or thymidine
incorporation, and staining for cell cycle markers such as Ki67,
PCNA, or phopho-H3. These methods provide a snapshot of the cell
cycle at speciﬁc time points, but cannot directly measure cell cycle
length or provide dynamic, temporal information. The recent design
of a Fluorescent, Ubiquitin-based, Cell Cycle Indicator system (Fucci)earch, 1000 E. 50th St, Kansas
rights reserved.as a dual construct, ﬂuorescent reporter system allows for the visual-
ization of the spatiotemporal dynamics of cell cycle progression
(Sakaue-Sawano et al., 2008a). The Fucci system has two compo-
nents: mAG-hGem (1/110), which produces a green ﬂuorescence sig-
nal during G2/S (and very little in M) and mKO2-hCdt1 (30/120)
which produces an orange ﬂuorescence signal during G1. Because
each protein in the Fucci system is rapidly degraded after their re-
spective phase of the cell cycle is complete, decreasing ﬂuorescent in-
tensities of mAG-hGem (1/110) and mKO2-hCdt1 (30/120) mark the
transitions between particular cell cycle phases.
Since its original design, modiﬁcations to Fucci have included al-
tering the ﬂuorescent proteins attached to hGem or hCdt1, localizing
the hCdt1-dependent reporter to the cytoplasm rather than to the nu-
cleus, and designing Fucci reporters based on the zebraﬁsh versions of
Cdt1 and Geminin (Sakaue-Sawano et al., 2008b; Sugiyama et al.,
2009). However, none of the Fucci designs provide a ﬂuorescent read-
out through the late M/early G1 phases or describe a quantitative
framework that would allow for automated cell cycle measurements.
Also, the systemmay be cumbersome to apply since it requires the in-
troduction of two separate plasmids. These limitations of Fucci may
lead to inefﬁcient labeling of all cells in culture or in an embryo, an in-
ability to track cell position during mitosis and difﬁculty in measuring
cell cycle phase progression from time-lapse imaging data.
To overcome these limitations, we have developed CycleTrak, a
novel, single-plasmid system that provides a ﬂuorescent readout of
G1 and continuous tracking of cell position through all phases of the
cell cycle. As part of the CycleTrak system, we also developed semi-
automated analysis tools to interrogate dynamic information on cell
cycle progression from time-lapse images and to more accurately de-
termine cell cycle progression with single cell precision. To validate
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HeLa cells and a highly aggressive metastatic melanoma cell line
(Welch et al., 1991). We found that CycleTrak provided the same dy-
namic cell cycle phase resolution as Fucci, but uniquely allows the use
of automated cell tracking programs to follow cell position and cell
cycle progression in ﬂuorescently labeled cells over time. Also, the
semi-automated quantitative analysis tools of CycleTrak allowed us
to track cell cycle dynamics in both individual and populations of
cells simultaneously. These features are unique to CycleTrak and, par-
ticularly for in vivo and embryonic imaging, provide distinct advan-
tages over cell cycle analysis using Fucci.Materials and methods
Cell culture
HeLa.S-Fucci are a variant of the human cervical carcinoma cell
line HeLa.S that express Fucci-Orange-G1 and Fucci-Green-S/G2/M
(Sakaue-Sawano et al., 2008a), and were kindly provided by the Cell
Bank of the RIKEN BioResource Center (cat. #RCB2812). HeLa.S-Fucci
cells were grown in DMEM with 10% fetal bovine serum (FBS) at 37 °C
in 5% CO2.
C8161 cells, a highly metastatic melanoma, were a kind gift from
Mary Hendrix (Children's Memorial Research Center, Northwestern
University) and were grown in RPMI with 10% FBS.Construction and conﬁrmation of single-vector Fucci reporters
To allow for simultaneous expression of both Fucci proteins, Fucci-
Orange-G1 and Fucci-Green-S/G2/M were PCR ampliﬁed, linked via
the porcine teschovirus-1 2A peptide sequence (P2A) (Szymczak-
Workman et al., 2007) and cloned into the EcoRI and XbaI sites of
pcDNA3.1(+) (Invitrogen). In order to allow for automated tracking
of cells through time, H2B-eGFP was PCR ampliﬁed and inserted
into the BspEI and XbaI sites of the dual Fucci vector to generate a
plasmid expressing both Fucci-Orange-G1 and a nuclear-localized
H2B-eGFP (Fig. 1b). For infection of the C8161 cells, we transferred
the Fucci-Orange-G1/2A/H2B-eGFP cassette into the PstI and Acc65I
restriction sites of pLenti6 (Invitrogen) downstream of the PGK
promoter.Lentiviral preparation and infection
Lentiviral particles were prepared using the ViraPower Lentiviral
Packaging mix, Lipofectamine 2000, and the 293FT cell line according
to the manufacturer's directions (Invitrogen). Supernatant was col-
lected at 48 and 72 hours post-transfection, and was concentrated
using PEG precipitation. Brieﬂy, the supernatant was collected, spun
at 3000 rpm for 5 minutes and then ﬁltered using a 0.45 μm ﬁlter.
For the precipitation, 3 ml of ﬁlter-sterilized 40% PEG-8000 in PBS
and 180 μl FBS was added to each 9 ml of supernatant. The virus
was allowed to precipitate for at least 72 hours prior to pelleting at
1500g for 10 minutes. The supernatant was removed and the tube
was spun down again at 1500g for 1 minute to remove residual PEG
solution. The viral pellet was resuspended in culture media by gently
pipetting up and down, before being stored at −80 °C prior to use.
Supernatant was concentrated 1:500 to 1:1000, resulting in viral ti-
ters as high as 108 titerable units (TU)/ml.
For infection, C8161 cells were seeded into 24-well plates at 1×104
cells/well, and allowed to adhere overnight. The next day, the cells were
infected at various MOIs in culture media in the presence of 6 μg/ml
polybrene (Sigma-Aldrich) overnight, before undergoing a media
change. The cells were then expanded prior to in vitro time-lapse imag-
ing experiments or in vivo transplant experiments.Chick embryo transplant model
Metastatic melanoma cells (C8161) were trypsinized and resus-
pended at 4×106 cells/ml. A 20 μl drop with approximately 80,000
cells/drop was placed on a petri dish lid and grown for 40 hours. A typ-
ical subset of cells (in a cluster) was cut by glass needle from a larger
cell cluster grown in a hanging drop as described above. This reduced
the size of the cell cluster to ﬁt into a gap in the dorsal neural tube of
an e1.5 chick embryo made by separating the dorsal midline tissue of
the neural tube by glass needle and inserting the tumor cell cluster in-
side. Each tumor cluster contained approximately 300–500 cells.Time-lapse imaging
For in vitro imaging, cells were seeded in a glass-bottom petri dish
(MatTek Corp.). Images were taken on a Zeiss 510 inverted confocal
microscope using a 488 nm laser for GFP and a 543 nm or a 560 nm
laser for mKO2, and were collected at 1024×1024 pixels every 6 mi-
nutes. In vivo imaging was performed as previously described (Kulesa
et al., 2010). Brieﬂy, chick embryos (after tumor cell transplantation)
were ﬁtted with a Teﬂon window and placed on an upright Zeiss 710
confocal microscope. Embryos were imaged in ovo and z-stack im-
ages were collected with 9 slices (for a total of 62 μm) every 10
minutes.Cell tracking
Cell nuclei were tracked using Imaris (Bitplane Inc.) using the
spots function. Spot size was set to the average size of a nucleus
(12 μm) and cells were tracked for the entire time they were visible
in the ﬁeld of view. Tracks were visually veriﬁed to be sure that one
track represented the same cell for the duration of the track. Spots' in-
tensity data were exported and analysis was completed using a
MATLAB (Mathworks Inc.) function. Though Imaris was used, the
MATLAB algorithm can be applied to any data for translational use
with other tracking software.Intensity analysis and automated assignment of phase
Cells often have a wide variety of mKO2-hCdt1 (30/120) ﬂuores-
cence intensities from cell to cell and also from cycle to cycle within
a single cell so simple threshold analysis was insufﬁcient. Local mini-
ma were found in the ﬂuorescence time trace to approximate the
time of M phase, and then veriﬁed by checking that the intensity
was less than 15% of the total range of mKO2 intensities. A temporary
threshold was created, multiplying each local minima by a user de-
ﬁned parameter. When the mKO2 intensity crossed this threshold, a
start of G1 was marked for each minima found. The completion of
G1 was marked at the site of local maxima. As soon as the mKO2 in-
tensity started to decrease, S/G2 began and this phase continued
until M phase was reached.
M phase demarcation used the H2B-eGFP intensity by exploiting
the fact that as a cell “rounded up” to divide, the cell either pulled
up off the glass in vitro causing a decrease in mean intensity or in
vivo, the condensed chromatin caused an increase in mean intensity.
We therefore looked for changes in H2B-eGFP intensity greater than a
certain number standard deviations from the mean. We found 2.5
worked well for our cells. This potential M phase was veriﬁed by
ﬁrst checking that the cell had not already been deﬁned in G1 and
second that a G1 phase started within 20% of the estimated total
cell cycle time after our potential M phase beginning. If the conditions
were met, the start of M phase was deﬁned and all time points be-
tween here and the start of G1 were deﬁned as M. All remaining
time points in the trace were deﬁned as S/G2.
Fig. 1. Comparison of cell cycle dynamics using Fucci versus CycleTrak systems. (A) Two-plasmid Fucci system withM phase (arrowhead) and beginning of G1 (asterisk), when little
or no ﬂuorescence signal is visible. (B) Single-plasmid CycleTrak system displays red and green ﬂuorescence signals during G1 (asterisk) and green ﬂuorescence signal (H2B-eGFP)
throughout the remaining cell cycles, including M phase (arrowhead). (C) A graph of the normalized intensities of red and green ﬂuorescence of Fucci-labeled HeLa cells. mKO2-
hCdt1 (30/120) ﬂuorescence (red) increases at the onset of G1 and begins to degrade at the onset of S phase, concomitant with an increase in hGem-mAG ﬂuorescence (green).
Green ﬂuorescence decreases with the onset of mitosis, leaving a brief period in late M/early G1 during which no ﬂuorescence is visible. (D) A graph of the normalized intensities
of red and green ﬂuorescence of CycleTrak-labeled metastatic melanoma cells. CycleTrak-labeled cells are green through all phases of the cell cycle, including mitosis (arrow). The
red signal continues to ﬂuctuate due to changes in the cell cycle, with an increase in mKO2-hCdt1 (30/120) intensity at the beginning of G1 (arrowhead), followed by a decrease in
the mKO2-hCdt1 (30/120) intensity at the onset of S phase (asterisk). (E) Representative images from confocal time-lapse movies of Fucci-labeled and CycleTrak-labeled cells in
vitro. In Fucci-labeled HeLa cells (upper panels), red ﬂuorescence increases in G1, decreases at the onset of S and is absent in G2 and M. The loss of ﬂuorescence signal immediately
following mitosis (arrowhead) makes it difﬁcult to track cells during this phase. In CycleTrak-labeled metastatic melanoma cells (lower panels), the green ﬂuorescence signal is
present in all phases of the cell cycle, allowing for cell tracking throughout the entire cell cycle.
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Fifty tracked cells were analyzed by hand for the time at which
each phase of the cell cycle began. The start of M phase was deﬁned
by a retraction of the cell's extended processes and the end upon
the reemergence of the cellular extensions. G1 was deﬁned as begin-
ning with the ﬁrst detection of red ﬂuorescence and ending at the
maximal red intensity. The results were compared to the same 50
cells analyzed by the MATLAB code and the results agreed within 15
minutes of the manually annotated data.
Results
Development of CycleTrak as a single plasmid system that allows for cell
cycle phase and cell position readout
The original Fucci constructs designed by the Miyawaki laboratory
used two plasmids and exploited the cyclical expression and degrada-
tion of Cdt1 and Geminin as a means of tracking cell cycle progression
(Sakaue-Sawano et al., 2008a). We harnessed the most informative
component of Fucci, mKO2-hCdt1 (30/120) which speciﬁcally labels
cells in G1, and coupled it with a nuclear-localized eGFP that expresses
throughout the entire cell cycle (compare Fig. 1A, B and C, D; see Sup
Movies 1 and 3). These proteins are separated by a 2A self-cleaving pep-
tide sequence, allowing them to be expressed simultaneously and in
equimolar amounts from the same promoter (de Felipe et al., 2006).
The nuclear-localized eGFP is constantly expressed so that single cell
identiﬁcation and tracking may be accurately automated, even during
mitosis (Fig. 1E; see Sup Movies 2 and 3).
We veriﬁed that our single-plasmid system did not affect cell cy-
cling and that we were able to discretely distinguish S/G2, M and
G1 phases (Fig. 1D; see SupMovies 1–3). We showed that the ﬂuores-
cence readout using CycleTrak was distinct from that of Fucci, demon-
strating that CycleTrak-labeled cells were visible throughout all
phases of the cell cycle (Fig. 1E and Sup Movie 3) and were efﬁciently
tracked (Sup Movie 2). For clarity of visualizing cell cycle progression
in individual cells, we chose to present subregions where cells were
more sparsely distributed.
Generation of the CycleTrak cell tracking and quantitative analysis
software
We exploited the phase-speciﬁc ﬂuorescent readouts of the Cycle-
Trak plasmid to create a MATLAB function that automatically assigned
cell cycle phase for single cells, based on ﬂuorescence intensity. Using
CycleTrak, an increase in mKO2-hCdt1 (30/120) intensity marked the
onset of G1 phase (Fig. 1D, arrowhead). Thus, we were able to distin-
guish M phase by a rapid change in the average eGFP ﬂuorescence in-
tensity as a cell began chromosomal segregation (Fig. 1D, arrow; see
Sup Movie 1). S/G2 phase was marked by the onset of degradation of
mKO2 ﬂuorescence intensity and constant eGFP ﬂuorescence signal
(Fig. 1D, asterisk). Thus, our single-plasmid CycleTrak system and quan-
titative tools provided a seamless analysis of cell cycle progression.
Since every cell may display different overall ﬂuorescence intensity,
this could present a roadblock to proper cell cycle analysis. Our analysis
was based on relative changes in intensity over time. That is, our meth-
od for cell identiﬁcation and tracking was not affected by cell-to-cell
variability in ﬂuorescence intensity any more than other variables
such as size and shape. Our method for segmenting out phases of the
cell cycle is capable of handling ﬂuorescence intensity changes with
each cycle. Thus, our method based on relative changes in intensity is
robust and overcomes this roadblock such that future studies will not
need to generate a stable cell line in order to use the CycleTrak system.
We used a commercial software package (Imaris, Bitplane) to
identify and track cells; however, any tracking software can be used
to then interface with our MATLAB routines for analysis. We decidedto use commercial software as the basis to integrate our cell cycle
analysis algorithm. That is, instead of writing an entirely new cell
tracking program that would not be user-friendly, cell type speciﬁc,
or easily distributable to a wide audience within the community, we
took advantage of a well-established commercial cell tracking pro-
gram that allowed integration of externally-generated algorithms.
Using a basic package to track cells showed that our system was
easy to use. Additionally, users will not be required to use specialty
software that is unfamiliar or that may not work optimally with
their cell lines or embryos. Thus, our algorithm for cell cycle analysis
will integrate with other cell tracking software that is user selected.
Validation of the CycleTrak system in vitro and identiﬁcation of cell cycle
heterogeneities in cultured human metastatic melanoma cells
One of the major readouts of cancer progression is tumor growth.
Studies of cell growth kinetics in tumors have shown that the dura-
tion of the cell cycle and the proportion of actively dividing cells are
crucial to tumor growth in vivo (Ho and Dowdy, 2002). However, es-
timations of tumor growth as assessed by typical static methods are
prone to error due to limitations in dynamic cell cycle analysis. We
applied CycleTrak to ﬂuorescently label, accurately track, and then
analyze cell cycle progression in individual human metastatic mela-
noma cells (Fig. 2; see Supplementary Movies 1 and 2). Our CycleTrak
analysis of metastatic melanoma cells (n=55 cells) in vitro estimated
the lengths (± standard deviation) of M, G1, and S/G2 as 1±0.9, 9±
3.7 and 11±3.4 hours, respectively. This predicted a total cell cycle
length of approximately 21 hrs±3.4, which agreed with estimates
from manual measurements of the data and with reports from the
literature (Zhu et al., 2004). We plotted the distribution of the total
cell cycle time for all cells that completed at least one full cycle
and found a wide variability within the population of cells (Fig. 2D).
This variability would not have been detected without the ability to
dynamically track cell cycle progression in individual cells. The vari-
ability in cell cycle was likely due to inherent heterogeneities within
the population of our melanoma cells (see Sup Movie 1). Thus,
using CycleTrak, it would be possible to examine both population
and individual cell cycle responses to an application of a drug or a
change in microenvironment.
Novel in vivo cell cycle dynamics of human metastatic melanoma cells in
a chick embryo transplant model as revealed by the CycleTrak system
To study the cell proliferation dynamics of human metastatic mel-
anoma cells in vivo, we took advantage of our chick embryo trans-
plant model system for studying single human tumor cell behaviors
in vivo. We have previously shown that human metastatic melanoma
cells transplanted into the chick embryonic neural crest microenvi-
ronment invaded and moved along stereotypical host neural crest
cell migratory pathways (Kulesa et al., 2006). Here, we transplanted
small subpopulations of human metastatic melanoma cells (~300–
500 cells), ﬂuorescently-labeled with our single-plasmid CycleTrak
system, into the dorsal neural tube of early-stage chick embryos
(Fig. 3A; see Sup Movie 4). Our in vivo experiments revealed 3 main
conclusions. First, cells that remained at the transplant site were
more likely to be found in G1 (Fig. 3B, Fig. 4B). Second, upon exit
from the transplant site and migration along host neural crest cell mi-
gratory pathways, tumor cells resumed cycling and continued to cycle
during their invasion throughout the chick embryo (Fig. 3B–D, com-
pare Fig. 4A, B; see Sup Movie 4). Third, our cell population analysis
of transplanted tumor cells resulted in only a 4% phase classiﬁcation
error compared to measurements by hand, and allowed for examina-
tion of cell-to-cell variation (Fig. 3C). In comparison, other models
that used the Fucci system to acquire whole-ﬁeld information based
on the ﬂuorescence intensity obtained only gross changes in the per-
cent of cells in a particular cell cycle phase (Sakaue-Sawano et al.,
Fig. 2. Visualization and analysis of human cancer cell cycle dynamics in vitro using CycleTrak. (A) Unsynchronized human metastatic melanoma cells imaged in culture using con-
focal time-lapse microscopy for approximately 66 hours. A sampling of cell trajectories is shown. (B) A typical image from a confocal time-lapse session showing human metastatic
melanoma cells in different cell cycle phases. (C) The graph shows the percentage of cells assigned to each cell cycle phase at every time point. (D) Histogram of total cell cycle
length for all cells that completed at least one full cycle. Note the wide degree of variability in cell cycle length at the single cell level.
Fig. 3. Visualization and analysis of human cancer cell cycle dynamics in vivo using CycleTrak. (A) Schematic of our in vivo chick embryo transplant model system. (B) Represen-
tative transplant after 24 hours of culture time with metastatic melanoma cells exhibiting all phases of the cell cycle within the embryonic neural crest microenvironment. Square
boxes highlight examples of 3 melanoma cells in either G1 or S/G2 cell cycle phases. (C) Graph of the red and green ﬂuorescent intensity traced over time for a typical, individual
melanoma cell captured during an in ovo confocal time-lapse imaging session. Phases of the cell cycle as determined by CycleTrak are shown above the graph. The cell ﬁrst exits the
clump 30 minutes after the start of the time-lapse (arrow). (D) Cell from (B) at four different time points showing different phases of the cell cycle within the embryo. At time=0,
the cell is located within the transplant site. Over the course of the time-lapse session, the cell migrates away from the transplant site and into the embryonic environment. The cell
begins in G1 phase and starts to cycle as it migrates, shortly after exiting the transplant.
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Fig. 4. Comparison of in vitro and in vivo cell cycle dynamics of human metastatic melanoma cells using CycleTrak. (A) Upper panel—the average mKO2/eGFP intensity ratio (R/G)
for all cells in a representative in vitro confocal time-lapse imaging session as a function of distance from the edge of the ﬁeld of view. Lower panel—distribution of R/G ratios of the
left and right half of the ﬁeld of view showing no signiﬁcant difference (n=~4000 cells, p=0.47 by K-S test). (B) Upper panel—the average R/G ratio for all cells in the in vivo
transplant time-lapse as a function of distance from the center of the transplant site. The transplant is approximately 90 μm in diameter. Lower panel—distribution of R/G ratios
showing a signiﬁcant difference (n=4559 cells, p=1.1x10e-213 by K-S test) between the ratios of cells still located within the transplant site and the ratios of cells that have mi-
grated into the embryonic environment.
194 D.A. Ridenour et al. / Developmental Biology 365 (2012) 189–1952011). In addition, only one other method describes single cell track-
ing using cell cycle-speciﬁc probes, and the non-automated results in-
cluded only a small fraction of the population (Hahn et al., 2009).
Discussion
The ability to accurately determine cell cycle phase and cell posi-
tion in single and subpopulations of cells in vitro and in vivo at high
spatiotemporal resolution using our newly developed CycleTrak sys-
tem overcomes a major roadblock in cell dynamics analysis. CycleTrak
allows cell cycle analysis in living tissue, unlike current static
methods, such as BrdU and immunostaining, that require ﬁxation. In
addition, Fucci and other dynamic cell cycle-speciﬁc probes only pro-
vide general observations about large scale proliferative events. This
is because of a lack of accurate cell tracking capability through late
M/early G1 (Sakaue-Sawano et al., 2008a) or G1 to S/G2 (Hahn et
al., 2009). This makes the analysis of large numbers of cells during dy-
namic processes very labor intensive and time consuming. Although
there is a slight decrease in CycleTrak's ability to resolve early G1
from G2 in analysis of static images (because of constant green ﬂuo-
rescence signal and the lack of red ﬂuorescence), CycleTrak over-
comes the current roadblock of Fucci and other cell cycle reporters
by allowing the tracking and visualization of all phases of the cell
cycle through time. Thus, CycleTrak is unique in its ability to interro-
gate cell proliferation dynamics in single cells, or in small subpopula-
tions of cells, particularly within a developing embryo.
Because of the ability to automate cell tracking and the quantitation
of ﬂuorescence signals, CycleTrakmay be especially well suited for ana-
lyzing large-scale 3D data sets. Emerging imaging technologies, such as
sheet plane illumination microscopy (SPIM) (Keller et al., 2010; Truong
et al., 2011), have been elegantly applied to visualize Drosophila and
zebraﬁsh embryogenesis and offer one example. High content screening
may also beneﬁt from using the CycleTrak system, since multiple wells
may be rapidly screened for changes in cell cycle progression in the
presence of various siRNA or chemical compound treatments. Other ap-
plication areas for CycleTrak include cancer growth and metastasis and
stem cell biology, where the accurate readout of cell cycle progressionand cell position would shed light on whether changes in cell cycle pro-
gression predict metastatic behavior and niche size, respectively.
The goal of this study was to generate a novel ﬂuorescent reporter
system and analytical tools for automated analysis of cell cycle pro-
gression. We have shown proof of principle of this system in vitro
in human cell lines and in vivo by transplantation of human cancer
cells into a chick embryo metastasis model. We believe the genera-
tion of transgenic animal models based on our CycleTrak reporter sys-
tem will be exciting and will become a valuable resource for the
developmental biology community.
In summary, we have created a single plasmid vector and semi-
automated tools, called CycleTrak. CycleTrak allows for higher ﬁdelity
visualization and analysis of cell cycle phase and cell position than cur-
rent methods. As a single plasmid system, CycleTrak enables a more ef-
fective delivery method capable of providing a ﬂuorescent readout of
G1 and cell nucleus position. The cell labeling strategy and software
tools of CycleTrak allow for enhanced studies of cell cycle regulation
owing to a more accurate means to identify and determine cell cycle
phase and cell position than previous methods. This is largely due to
the cell cycle readout of CycleTrak being based on the presence or ab-
sence of nuclear localized ﬂuorescence signal, rather than on localiza-
tion of signal within different subregions of a cell (Hahn et al., 2009)
and ﬂuorescence through all cell cycle phases, unlike Fucci (Sakaue-
Sawano et al., 2008a). We have validated CycleTrak and applied it in
practice to identify heterogeneities in human cancer cell cycle progres-
sion in cultured metastatic melanoma cells and to follow in vivo single
cell cycle progression after cell transplantation into a chick embryo
model. We suggest that CycleTrak offers a powerful approach distinct
from current techniques and is broadly applicable to cell proliferation
questions in development, cancer, and regeneration.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ydbio.2012.02.026.
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